FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CGMP Violations at Oasis Medical

[ Price : $8.95]

FDA warns Glendora, CA-based Oasis Medical about CGMP violations in its production of finished drugs.

Laura Loomer Targets Makary Over Prasad Exit

[ Price : $8.95]

Right-wing commentator Laura Loomer publicly criticizes FDA commissioner Marty Makary over recent comments surrounding the departu...

Former FDA Staff Chief Joins Hogan Lowells

[ Price : $8.95]

Former FDA chief of staff Elizabeth Jungman joins law firm Hogan Lovells as a partner in its pharmaceuticals and biotechnology pra...

Vertex Signal Inhibitor VX-993 Misses Trial Goal

[ Price : $8.95]

Vertex Pharmaceuticals says it will not pursue its investigational VX-993 as monotherapy for acute pain following bunionectomy sur...

FDA Publishes Data Standards Program Update

[ Price : $8.95]

FDA publishes the FY 2025 Quarter 2 update to the CBER/CDER Data Standards Program Action Plan.

Clarametyx Gets Fast Track for Pulmonary Infection Drug

[ Price : $8.95]

FDA grants Clarametyx Biosciences both fast track and qualified infectious disease product designations for its lead therapeutic c...

Mectronic Medicale Multiple Violations

[ Price : $8.95]

FDA warns Italys Mectronic Medicale about Quality System, Medical Device Reporting, and other violations in its illegal manufactur...

Two-Day Workshop on Oncology Patient Registries

[ Price : $8.95]

FDAs Oncology Center of Excellence announces a two-day virtual public workshop to advance the development of patient registries in...

Dyne Gets Breakthrough Status for Duchenne Therapy

[ Price : $8.95]

FDA grants Dyne Therapeutics a breakthrough therapy designation for DYNE-251 for treating patients with Duchenne muscular dystroph...

TransMedics Gets Heart Trial Conditional Approval

[ Price : $8.95]

FDA grants TransMedics Group conditional approval to begin its next-generation Organ Care System ENHANCE heart trial.